Stockscreener 앱 받기
0.2769
2.56%
0.0069
시간 외 거래:
.28
0.0031
+1.12%
Catheter Precision Inc. 주식(VTAK)의 최신 뉴스
Catheter Precision (VTAK) Reveals Enhanced Clinical Data on VIVO System | VTAK Stock News - GuruFocus
New Clinical Data Presented about VIVO at the 46th Annual Heart Rhythm Association Conference - The Manila Times
Catheter Precision Inc [VTAK] Director makes an insider purchase of 3 shares worth 1.0. - knoxdaily.com
Catheter Precision to Attend and Participate in the 46th Heart R - GuruFocus
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society | VTAK Stock News - GuruFocus
Catheter Precision to Attend and Participate in the 46th Heart Rhythm Society - The Manila Times
Breakthrough Cardiac Study: Catheter Precision's VIVO System Achieves 94% Accuracy in European Multi-Center Trial - Stock Titan
Catheter Precision to acquire late-stage heart failure treatment assets in development - MSN
Analytical Lens: Exploring Catheter Precision Inc (VTAK)’s Financial Story Through Ratios - DWinneX
Catheter Precision Inc (VTAK) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Can Catheter Precision Inc (VTAK) meet market expectations this quarter? - uspostnews.com
How analysts predict Five9 Inc (FIVN) will perform this quarter? - uspostnews.com
Catheter Precision (VTAK) Acquires Assets for Cardiac Technology Expansion | VTAK Stock News - GuruFocus
Catheter Precision to acquire assets of Cardionomic related to CPNS system - TipRanks
Catheter Precision to Acquire Assets in Development for Late-Stage Treatment for Acute Decompensated Heart Failure - The Manila Times
Catheter Precision To Acquire Assets In Development For Late-Stage Treatment For Acute Decompensated Heart Failure - marketscreener.com
Breakthrough Heart Failure Treatment Tech With 1M Patient Potential Acquired: Early Clinical Success Revealed - Stock Titan
Catheter Precision Reports 'Going Concern' Notice in Recent Annual Report - marketscreener.com
Catheter Precision Makes NYSE American Section 610(b) Public Announcement - The Manila Times
Catheter Precision Makes NYSE American Section 610(b) Public Announcement | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Announces Receipt of Audit Opinion with Going Concern Doubt - Nasdaq
Crude Oil Gains a Dollar Off China-U.S. Optimism, U.S. EIA Data - The Globe and Mail
Tariff-Driven Volatility Impacting Wall Street Trading Desks - The Globe and Mail
Too Quiet? AI Chip Curbs Ignite Selling—Can Bulls Bounce Back? - The Globe and Mail
Slate Grocery REIT Announces Distribution for the Month of April 2025 - The Globe and Mail
Catheter Precision (VTAK) Secures US Patent for Surgical Closure Device | VTAK Stock News - GuruFocus
Catheter Precision, Inc. Receives Notice of First Patent Allowance in the US for LockeT Product Line - GlobeNewswire
Lachine Hospital Foundation Gala raises $406,500 to support the modernization of Lachine Hospital - The Manila Times
Major Patent Win: Catheter Precision's LockeT Device Gets US Protection Amid Global Expansion - Stock Titan
S&P 500 loses 5%, more than half its prior historic gain, after White House clarifies US is tariffing China at 145% - The Globe and Mail
Tesla Stock’s (TSLA) Tariff Surge Turns Into a Skid - The Globe and Mail
VTAK stock touches 52-week low at $0.3 amid market challenges - Investing.com
VTAK stock touches 52-week low at $0.3 amid market challenges By Investing.com - Investing.com South Africa
Catheter Precision Inc. (VTAK) reports earnings - Quartz
Catheter Precision Q4 2024 revenue jumps 55% to USD 149K - Medical Buyer
Catheter Precision, Inc. Announces Fourth Quarter and Full Year 2024 Update and Financial Results - GlobeNewswire
Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure - The Manila Times
Catheter Precision Reports 55% Revenue Jump as LockeT Adoption Accelerates - Stock Titan
Catheter Precision to Participate in and Share Data at Upcoming Industry Conferences - The Manila Times
Breakthrough Study: Catheter Precision's LockeT Outperforms Traditional Methods in 97-Patient Trial - Stock Titan
Imperative Care Expands Precision Thrombectomy Portfolio - Diagnostic and Interventional Cardiology
Imperative Care Expands Symphony Precision Thrombectomy Portfolio with Purpose-Built Design for the Treatment of Venous Thrombosis - Business Wire
VTAK stock touches 52-week low at $0.31 amid market challenges - Investing.com Australia
VTAK stock touches 52-week low at $0.31 amid market challenges By Investing.com - Investing.com South Africa
Global 3D Cardiac Mapping System Market To Reach $2.73 Billion By 2029 With A Growth Rate Of 9.6% As Reveal... - WhaTech
3D Cardiac Mapping System Market To Reach $2.73 Billion By 2029 With A Growth Rate Of 9.6% - WhaTech
Catheter Precision to Attend and Participate in the Western Atrial Fibrillation Symposium - The Manila Times
Catheter Precision's LockeT Innovation Takes Center Stage at Elite AF Symposium - StockTitan
Ra Medical : Reports First Quarter 2019 Financial Results -May 13, 2019 at 04:07 pm EDT - Marketscreener.com
Global Magnetic Ablation Catheters Market Poised for Significant Growth, Projected to Reach USD 1,114.4 Million by 2035 Driven by Technological Advancements and Rising Cardiovascular Cases | Future Market Insights, Inc. - GlobeNewswire
Catheter Precision Inc. Engages PCG Advisory to Broaden Investor Relations Strategy - The Manila Times
ACT-ion Raises $7.5 million in Pre-Series A Round Led by BASF Venture Capital - The Manila Times
11.62%
0.20%
자본화:
|
볼륨(24시간):